[Basedow's disease and interferon for hepatitis C. Recurrence as Basedow's ophthalmopathy after interferon reintroduction].
Huet
D
D
Entremont
A
A
Hautecouverture
M
M
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D013956:Antithyroid Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015551:Autoimmunity; D002231:Carbimazole / Q000627:therapeutic use; D006111:Graves Disease / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D012008:Recurrence; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D013956:Antithyroid Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D002231:Carbimazole; D008775:Methylprednisolone